Open access
Aug 2026
Tumor Treating Fields (TTFields) sensitize anti-PD1-resistant lung tumors to PD1 blockade and remodel myeloid and lymphoid states
TTFields sensitized anti-PD1-refractory lung tumors to PD1 blockade and induced coordinated remodeling of tumor-cell fitness and the tumor immune microenvironment, identifying TTFields as a potential tumor-conditioning strategy for overcoming resistance to immune checkpoint blockade.
Yun Hu, Fatemeh Maspourour, Qi Wang et al.
· Research Square · 0 citations